Bloomberg Originals
@business·5.1M subscribers·49.5K videos
How India's Drug Exports May Have a Safety Problem
Posted
December 15, 2023
Views
72,785
Likes
1,764
Comments
317
Engagement
2.86%
December 15, 2023
72,785
1,764
317
2.86%
Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
9:04Now PlayingIn 2019, doctors at hospitals in Colombia began reporting that patients treated with a commonly used cancer drug were developing high fevers, “altered states of consciousness” and other concerning symptoms.
They suspected that more than 100 patients had suffered reactions linked to the contaminated medicine. Four children died, including a six-year-old girl named Valery.
The drug they were given was made by Naprod Life Sciences in India, a crucial but sometimes unnoticed maker of low-cost generic cancer medicine. None of the medicine the company makes is approved for sale in the US, where regulations are tougher. Naprod can sell some medicine in Europe but said it currently is not.
This is the story of how a drugmaker with a record of safety lapses and quality concerns keeps selling medicine, leaving patients and families to suffer the consequences.
Read the full story
Get unlimited access to Bloomberg.com for $1.99/month for the first 3 months
--------
Like this video? Subscribe
Become a Quicktake Member for exclusive perks
Bloomberg Originals offers bold takes for curious minds on today’s biggest topics. Hosted by experts covering stories you haven’t seen and viewpoints you haven’t heard, you’ll discover cinematic, data-led shows that investigate the intersection of business and culture. Exploring every angle of climate change, technology, finance, sports and beyond, Bloomberg Originals is business as you’ve never seen it.
Subscribe for business news, but not as you've known it: exclusive interviews, fascinating profiles, data-driven analysis, and the latest in tech innovation from around the world.
Visit our partner channel Bloomberg Quicktake for global news and insight in an instant.
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.
